Menu
Wechat public account

Technologies

Healthcare Big Data and Artificial Intelligence
Smart Monitoring Skynet System for Major Epidemics

To respond to possible major outbreaks of emerging or re-emerging infectious diseases in the future, the country should establish a nationwide automatic epidemic monitoring and reporting system covering all provinces (autonomous regions, municipalities directly under the central government), Xinjiang Production and Construction Corps, as well as cities and counties. This system integrates novel pathogen detection technology with big data and AI technology to achieve networked, real-time, automated epidemic monitoring and early warning. The research institute has developed a Smart Monitoring Skynet System for Major Epidemics, which ensures "two firsts": first-hand data networking and first-time reporting. This allows decision-makers to keep abreast of the epidemic's development until its conclusion, forming a smart epidemic monitoring "Skynet" without any dead ends. In this way, when faced with the occurrence of an epidemic, or even the advent of biological warfare, the country can calmly and promptly take preventive measures to minimize the losses caused by the epidemic or war to people's lives, safety, and the national economy. The Skynet system consists of three core systems: a major epidemic pathogen detection equipment IoT system, a major epidemic pathogen detection system, and a major epidemic risk assessment and early warning system.



Information Platform for Mutual Recognition of Clinical Test Results

The goal of building an information platform for mutual recognition of clinical test results is to achieve automatic and real-time monitoring of indoor quality control and external quality assessment data for clinical testing institutions. This ensures the standardization of test results and provides support for the information platform of mutual recognition of clinical results. Specifically, the reporting and evaluation of indoor quality control and external quality assessment data include basic information maintenance, indoor quality control data reporting, indoor quality control data collection and information feedback, and monthly quality analysis reports for the laboratory. The dynamic management of automatic data collection and quality evaluation for indoor quality control and external quality assessment includes: a data transmission interface between clinical testing equipment and this system to achieve automatic data collection for indoor quality control; and dynamic management of laboratory quality evaluation based on automatically reported data.



Community Health Screening and Health Management Big Data System
The Community Health Screening and Health Management Big Data System aims to establish an end-to-end application system for chronic disease health prediction and intervention based on the community, with chronic disease health management as the core. It combines mobile health IoT and cloud computing technologies to provide decision support for government chronic disease prevention and control efforts. The system includes multiple subsystems such as data acquisition, data management, data visualization, WeChat official account, physician terminal, health management APP, and has obtained national information security level 3 protection registration. (1) The data acquisition system collects multi-dimensional health data through methods such as physical examination integrated machines, ocular examination instruments, and questionnaire APPs, including 13 physiological indicators, 5 biochemical indicators, as well as physical and ocular data. The encrypted data is then transmitted to the cloud data center. (2) The data management system supports safe and efficient storage and management of health screening data, and provides functions such as data reporting. (3) The data visualization system supports multi-dimensional data perspective and display. The system is divided into five major modules: basic population information, health status, testing items, lifestyle, and population distribution, which can display all health information of the population in real-time. (4) The WeChat official account is a new media system that supports diabetes screening services. The system provides functions such as user registration, diabetes screening, viewing of screening reports (including physical, medical examination, ocular examination, genetic testing, and complication detection), consultation, and message reception. (5) The physician terminal system supports online health management services. Physicians and health managers can use this system for user management, viewing health screening information, online health management services, and instant messaging with users. (6) The health management APP is a community version of the personal health management system. The system can realize user health records and evaluations, health management plan push, health report viewing, emotional regulation, and physical examination appointments.

Relying on the company's complete chronic disease prevention and control product system and comprehensive solutions, Bio-Technology conducted community health screening and management projects involving more than 180,000 people in Liangjiang New Area of Chongqing, Fuxin City, Liaoning Province, and Kunming City, Yunnan Province. In the communities under the jurisdiction of Liangjiang New Area of Chongqing, a two-year (2017-2018) diabetes screening and health management program has been completed for 100,000 permanent residents. On May 5, 2017, the public welfare project for diabetes prevention and control in the communities of Liangjiang New Area, Chongqing was successfully launched. Currently, the first and largest diabetes database of healthy people in China has been established, providing a demonstration and sample for chronic disease health management in China, valuable data and decision-making basis for improving the level of grass-roots health management of Chinese citizens, and also contributing to reducing the prevalence of diabetes among Chinese people.




Copyright © 2000-2023博奥生物集团有限公司 京ICP备14023013号-3

《互联网药品信息服务资格证书》: (京) - 非经营性-2016-0047 京公网安备11011402013114号